We are live on ! Find out more
PCVX icon

Vaxcyte
PCVX

223 hedge funds and large institutions have $6.51B invested in Vaxcyte in 2023 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 86 increasing their positions, 69 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

236% more call options, than puts

Call options by funds: $9.9M | Put options by funds: $2.94M

131% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 16

26% more capital invested

Capital invested by funds: $5.17B → $6.51B (+$1.34B)

25% more repeat investments, than reductions

Existing positions increased: 86 | Existing positions reduced: 69

10% more funds holding

Funds holding: 202 → 223 (+21)

8% more funds holding in top 10

Funds holding in top 10: 13 → 14 (+1)

0.88% more ownership

Funds ownership: 108.03% → 108.91% (+0.88%)

Holders
223
Holders Change
+21
Holders Change %
+10.4%
% of All Funds
3.25%
Holding in Top 10
14
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+7.69%
% of All Funds
0.2%
New
37
Increased
86
Reduced
69
Closed
16
Calls
$9.9M
Puts
$2.94M
Net Calls
+$6.96M
Net Calls Change
+$6.35M

Top Buyers

1
BlackRock
BlackRock
New York
+$60M
2
Morgan Stanley
Morgan Stanley
New York
+$34.5M
3
DGM
Darwin Global Management
Jersey
+$30.1M
4
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$23.5M
5
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$20M

Top Sellers

1
MVM
Medicxi Ventures Management
Jersey
-$53.5M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$32.3M
3
FAM
Fred Alger Management
New York
-$22M
4
NIP
Nicholas Investment Partners
California
-$18.1M
5
B
Braidwell
Connecticut
-$17.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
YIH
151
Y-Intercept (HK)
Hong Kong
$808K +$668K +12,859 New
LCM
152
Legato Capital Management
California
$766K +$77.8K +1,498 +14%
AQR Capital Management
153
AQR Capital Management
Connecticut
$760K -$20.8K -400 -3%
Creative Planning
154
Creative Planning
Kansas
$750K +$149K +2,875 +32%
JFG
155
Jefferies Financial Group
New York
$745K +$616K +11,869 New
LPL Financial
156
LPL Financial
California
$676K +$59.2K +1,139 +12%
SO
157
STRS Ohio
Ohio
$671K +$20.8K +400 +4%
Public Employees Retirement Association of Colorado
158
Public Employees Retirement Association of Colorado
Colorado
$629K -$64.6K -1,244 -11%
Allianz Asset Management
159
Allianz Asset Management
Germany
$628K +$77.9K +1,500 +18%
AIP
160
Ameritas Investment Partners
Nebraska
$596K +$14.4K +278 +3%
HS
161
HighVista Strategies
Massachusetts
$585K -$100K -1,927 -17%
Truist Financial
162
Truist Financial
North Carolina
$553K +$51.5K +991 +13%
EFM
163
E Fund Management
China
$532K +$3.12K +60 +0.7%
MYIA
164
Mount Yale Investment Advisors
Colorado
$515K +$3.22K +62 +0.8%
EA
165
Ellsworth Advisors
Ohio
$506K +$10.8K +207 +3%
SAM
166
Sectoral Asset Management
Quebec, Canada
$506K -$5.88M -113,180 -93%
UOC
167
UBS O'Connor
Illinois
$504K -$102K -1,970 -20%
BCI
168
Brinker Capital Investments
Pennsylvania
$443K +$54.5K +1,050 +17%
OPS
169
Orion Portfolio Solutions
Nebraska
$443K +$54.5K +1,050 +17%
PNC Financial Services Group
170
PNC Financial Services Group
Pennsylvania
$439K +$73.3K +1,411 +25%
Canada Life
171
Canada Life
Manitoba, Canada
$428K -$317K -6,110 -47%
Walleye Trading
172
Walleye Trading
New York
$423K +$350K +6,741 New
CPIG
173
Chicago Partners Investment Group
Illinois
$372K -$66.7K -1,285 -18%
CAPTRUST Financial Advisors
174
CAPTRUST Financial Advisors
North Carolina
$365K -$11.2K -215 -4%
X
175
Xponance
Pennsylvania
$356K +$8.46K +163 +3%
5 6
7
8 9

PCVX Hedge Fund Activity: Q4 2023 in Review

223 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Vaxcyte (PCVX) for Q4 2023, worth a combined $6.51B — up 26% from $5.17B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new PCVX positions and 16 closed out — a net gain of 21 holders — while 86 added to existing stakes and 69 trimmed.

The largest buyer was BlackRock, adding an estimated $60M. The largest seller was Medicxi Ventures Management, exiting entirely with an estimated $53.5M sold.

  • 223 institutional investors held Vaxcyte (PCVX) as of Q4 2023, up from 202 in Q3 2023.
  • Funds reported $6.51B of Vaxcyte stock for Q4 2023, up 26% quarter-over-quarter.
  • 37 funds opened new Vaxcyte positions in Q4 2023 and 16 closed out, a net change of +21 holders.
  • The largest Vaxcyte buyer in Q4 2023 was BlackRock, an estimated $60M added.
  • The largest Vaxcyte seller in Q4 2023 was Medicxi Ventures Management, an estimated $53.5M sold.

Based on aggregated 13F filings for Q4 2023.